久久亚洲国产成人影院-久久亚洲国产的中文-久久亚洲国产高清-久久亚洲国产精品-亚洲图片偷拍自拍-亚洲图色视频

Global EditionASIA 中文雙語Fran?ais
China
Home / China / Health

China approves first domestically produced nine-valent HPV vaccine

Xinhua | Updated: 2025-05-30 16:14
Share
Share - WeChat

XIAMEN -- China approved its first domestically developed nine-valent human papillomavirus (HPV) vaccine on Thursday, according to the National Medical Products Administration.

The vaccine, Cecolin 9, was jointly developed by the Xiang An Biomedicine Laboratory, Xiamen University and Wantai BioPharm. Its approval makes China the second country in the world — after the United States — with the capability to independently supply high-valency HPV vaccines.

Since 2019, the vaccine has been through five clinical trials conducted across China, involving more than 11,000 healthy volunteers aged nine to 45.

Results from these trials showed that the vaccine provides strong protection against HPV types 16 and 18 — the same strains covered by the two-valent vaccine — as well as five other HPV types 31, 33, 45, 52 and 58, with a protection rate of over 98 percent against persistent infections lasting more than 12 months and a 100 percent protection rate against cervical infections.

For girls aged nine to 17, just two doses are sufficient to produce an immune response comparable to that seen in women aged 18 to 26 who receive three doses. For girls aged 15 to 17, it is currently the only two-dose HPV vaccine available in China.

A comparative study showed that the new vaccine offers immune responses comparable with similar international products for at least 30 months after full immunization. These findings have been published in The Lancet Infectious Diseases.

The new vaccine is the latest achievement from the research team that also developed China's first domestically made two-valent HPV vaccine in 2019. In 2021, the two-valent HPV vaccine received prequalification from the World Health Organization (WHO) and has since entered the markets of 21 countries.

Cervical cancer was the fourth most common cancer among women worldwide in 2022, according to the WHO. China made free HPV vaccination accessible to approximately 40 percent of girls aged 13 to 14 in 2024, as part of its ongoing work to tackle cervical cancer, according to the National Health Commission.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 新久草视频 | 97国内免费久久久久久久久久 | 国产精品特黄毛片 | 人人操美女 | 香港激情黄三级在线视频 | 好叼操这里只有精品 | 久久精品一 | 一级特级欧美a毛片免费 | 欧美日韩精品乱国产 | 91无套极品外围在线播放 | a级毛片毛片免费很很综合 a级毛片免费 | 97操碰| 三级网站 | 九九九九在线精品免费视频 | 亚洲人成网站在线在线 | 欧美在线a | 香蕉久久一区二区不卡无毒影院 | 亚洲香蕉久久一区二区 | 成人影院人人免费 | 在线看片不卡 | 欧美一区二区三区久久综 | 久久精品片 | 国产精品久久久久久久久久日本 | 国内自拍网址 | 欧美久久久久久久一区二区三区 | 波多野结衣中文在线 | 欧美成人私人视频88在线观看 | 香蕉视频在线观看黄 | 有码日韩 | 国产在线精品一区二区夜色 | 日韩精品一区二区三区毛片 | 久草高清视频 | 色欧美与xxxxx | 日韩国产欧美精品综合二区 | 一区二区三区欧美视频 | 亚洲欧美另类自拍第一页 | 99久久久免费精品免费 | 2020久久国产最新免费观看 | 成人a在线 | 一级片免 | 国产精品成人免费视频不卡 |